Skip to main content
Premium Trial:

Request an Annual Quote

Erasmus MC Will Automate Exome Capture of 3,000 Samples for Epidemiology Study

Premium

Erasmus University Medical Center in Rotterdam, the Netherlands, is using Caliper Life Sciences' Sciclone NGS Workstation and Roche's NimbleGen SeqCap EZ Exome to automate exome capture and sequencing of more than 3,000 samples, the partners said this week.

The sequencing is being done as part of the Rotterdam Study, a large epidemiological study that includes 15,000 participants to identify genetic risk factors for age-related disorders such as osteoporosis, cardiovascular disease, Alzheimer disease, and type 2 diabetes.

Due to the automation, the Erasmus team expects to complete this portion of the study in the next three to four months. It was "the most optimal solution to analyze these thousands of DNA samples," André Uitterlinden, head of the genetic laboratory at Erasmus MC, said in a statement.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.